Impact of Ibis on Patients With Advanced COPD

Senscio Systems240 enrolled

Overview

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients with COPD.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

SUPPORTIVE_CARE

Masking

NONE

Enrollment

240

Conditions

COPD

Interventions

Digital TherapeuticsBEHAVIORAL

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * Gold Stage II with a CAT Score above 19 * Gold Stage III/IV with a CAT Score above 14 Exclusion Criteria: * Cognitive or physical impediments that inhibits patients from interacting with our digital therapeutics platform.

Outcomes

Primary Outcomes

Reduction in Acute Care Utilization

Time frame: 6 months and then again at 1 year

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.